Calcitonin gene-related peptide acts presynaptically to increase quantal size and output at frog neuromuscular junctions

Journal of Physiology

Volumn 507, Issue 3, 1998, Pages 689-695

  Van Der Kloot, William ^a,b   Benjamin, William B ^a   Balezina, Olga P ^a,c  

^a STONY BROOK UNIVERSITY   (United States)

^b STONY BROOK UNIVERSITY   (United States)

^c MOSCOW STATE UNIVERSITY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; CALCITONIN GENE RELATED PEPTIDE; CALCITONIN GENE RELATED PEPTIDE RECEPTOR; CYCLIC AMP DEPENDENT PROTEIN KINASE; POTASSIUM ION; VESAMICOL; CALCITONIN GENE RELATED PEPTIDE[8-37];

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DEPOLARIZATION; ENZYME ACTIVATION; FROG; MINIATURE ENDPLATE POTENTIAL; MOTOR NERVE; NERVE ENDING; NEUROMUSCULAR SYNAPSE; NONHUMAN; PRESYNAPTIC NERVE; PRIORITY JOURNAL; PROTEIN SECRETION; RADIOIMMUNOASSAY; SYNAPSE VESICLE; ANIMAL TISSUE; CONCENTRATION (PARAMETERS); EVOKED RESPONSE; MUSCLE BLOOD VESSEL; PRESYNAPTIC MEMBRANE; PROTEIN FUNCTION; RANA PIPIENS;

ACETYLCHOLINE; ANIMALS; ARACHIDONIC ACIDS; CALCITONIN GENE-RELATED PEPTIDE; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; ENZYME INHIBITORS; EVOKED POTENTIALS; HUMANS; KINETICS; MOTOR NEURONS; MUSCLE, SKELETAL; NEUROMUSCULAR JUNCTION; PATCH-CLAMP TECHNIQUES; PEPTIDE FRAGMENTS; PIPERIDINES; POLYUNSATURATED ALKAMIDES; QUANTUM THEORY; RANA PIPIENS; THIONUCLEOTIDES;

EID: 0032520874     PISSN: 00223751     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-7793.1998.689bs.x     Document Type: Article

References (37)

1. AMARA, S. G., JONAS, V., ROSENFELD, M. G., ONG, E. S. & EVANS, R. M. (1982). Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products. Nature 298, 240-244.
2. 3H]acetylcholine active transport by tetraphenylborate and other anions. Molecular Pharmacology 24, 55-59.
3. BRAIN, S. D., WILLIAMS, T. J., TIPPINS, J. R., MORRIS, H. R. & MACINTYRE, I. (1985). Calcitonin gene-related peptide is a potent vasodilator. Nature 313, 73-75.
4. CORREIA-DE-SÁ, P. & RIBEIRO, J. A. (1994). Potentiation by tonic A(2A)-adenosine receptor activation of CGRP-facilitated [h-3]-ACH release from rat motor nerve endings. British Journal of Pharmacology 111, 582-588.
5. CSILLIK, B., TAJTI, L., KOVACS, T, KUKLA, E., RAKIC, P. & KNYIHARCSILLIK, E. (1993). Distribution of calcitonin gene-related peptide in vertebrate neuromuscular junctions - relationship to the acetylcholine receptor. Journal of Histochemistry and Cytochemistry 41, 1547-1555.
6. 8.37, a calcitonin-gene-related peptide antagonist revealing calcitonin gene-related peptide receptor heterogeneity in brain and periphery. Journal of Pharmacology and Experimental Therapeutics 254, 123-128.
7. DEVANE, W. A., HANUS, I., BREUER, A., PERTWEE, R. G., STEVENSON, L. A., GRIFFIN, G., GIBSON, D., MANDELBAUM, A., ETINGER, A. & MECHOULAM, R. (1992). Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258, 1946-1949.
8. FATT, P. & KATZ, B. (1952). Spontaneous subthreshold activity at motor nerve endings. Journal of Physiology 117, 109-128.
9. GOLDBERG, A. L. & SINGER, J. J. (1969). Evidence for the role of cyclic AMP in neuromuscular transmission. Proceedings of the National Academy of Sciences of the USA 64, 131-141.
10. GOODMAN, E. C. & IVERSEN, L. L. (1986). Calcitonin gene-related peptide: Novel neuropeptide. Life Sciences 38, 2169-2178.
11. JINNAI, K., CHIHARA, K., KANDA, F., TADA, K. & FUJITA, T. (1989). Calcitonin gene-related peptide enhances spontaneous acetylcholine release from the rat motor nerve terminal. Neuroscience Letters 103, 64-68.
12. KASHIHARA, Y., SAKAGUCHI, M. & KUNO, M. (1989). Axonal transport and distribution of endogenous calcitonin gene-related peptide in rat peripheral nerve. Journal of Neuroscience 9, 3796-3802.
13. KIMURA, I., OKAZAKI, M. & NOJIMA, H. (1997). Mutual dependence of calcitonin gene-related peptide and acetylcholine release in neuromuscular preparations. European Journal of Pharmacology 330, 123-128.
14. KOBAYASHI, H., HASHIMOTO, K., UCHIDA, S., SAKUMA, J., TAKAMI, K., TOHYAMA, M., IZUMI, F. & YOSHIDA, H. (1987). Calcitonin gene-related peptide stimulates adenylate cyclase activity in rat striated muscle. Experientia 43, 314-316.
15. LEDERER, W. J., SPINDLER, A. J. & EISNER, D. A. (1979). Thick slurry bevelling. A new technique for bevelling extremely fine microelectrodes and micropipettes. Pflügers Archiv 381, 287-288.
16. LONGMORE, J., HOGG, J. E., HUTSON, P. H. & HILL, R. G. (1994). Effects of two truncated forms of human calcitonin-gene related peptide: implications for receptor classification. European Journal of Pharmacology 265, 53-59.
17. LU, B. & FU, W. M. (1995). Regulation of postsynaptic responses by calcitonin gene related peptide and ATP at developing neuromuscular junctions. Canadian Journal of Physiology and Pharmacology 73, 1050-1056.
18. LU, B., FU, W. M., GREENGARD, P. & POO, M. M. (1993). Calcitonin gene-related peptide potentiates synaptic responses at developing neuromuscular junction. Nature 363, 76-79.
19. MCEWAN, J. R., RITTER, J. M. & MACDERMOT, J. (1989). Calcitonin gene related peptide (CGRP) activates adenylate cyclase of bovine aortic endothelial cells: guanosine 5′ triphosphate dependence and partial agonist activity of a tyrosinated analogue. Cardiovascular Research 23, 921-927.
20. MARTIN, A. R. (1966). Quantal nature of synaptic transmission. Physiological Reviews 46, 41-66.
21. MIYAMOTO, M. D. & BRECKENRIDGE, B. M. (1974). A cyclic adenosine monophosphate link in the catecholamine enhancement of transmitter release at the neuromuscular junction. Journal of General Physiology 63, 609-624.
22. POYNER, D. R. (1992). Calcitonin gene-related peptide: multiple actions, multiple receptors. Pharmacology and Therapeutics 56, 23-51.
23. POYNER, D. R. (1995). Pharmacology of receptors for calcitonin gene-related peptide and amylin. Trends in Pharmacological Sciences 16, 424-428.
24. POYNER, D. R., ANDREW, D. P., BROWN, D., BOSE, C. & HANLEY, M. R. (1992). Pharmacological characterization of a receptor for calcitonin gene-related peptide on rat, L6 myocytes. British Journal of Pharmacology 105, 441-447.
25. PRIOR, C., MARSHALL, I. G. & PARSONS, S. M. (1992). The pharmacology of vesamicol - an inhibitor of the vesicular acetylcholine transporter. General Pharmacology 23, 1017-1022.
26. ROTHERMEL, J. D., STEC, W. J., BARANIAK, J., JASTORFF, B. & BOTELHO, L. H. P. (1983). Inhibition of glycogenolysis in isolated rat hepatocytes by the Rp diastereomer of adenosine 3′,5′-phosphorothioate. Journal of Biological Chemistry 258, 12125-12128.
27. SAKAGUCHI, M., INAISHI, Y., KASHIHARA, Y. & KUNO, M. (1991). Release of calcitonin gene-related peptide from nerve terminals in rat skeletal muscle. Journal of Physiology 434, 257-270.
28. TOMLINSON, A. E. & POYNER, D. R. (1996). Multiple receptors for calcitonin gene-related peptide and amylin on guinea-pig ileum and vas deferens. British Journal of Pharmacology 117, 1362-1368.
29. UCHIDA, S., TAKAMI, K., KOBAYASHI, H., HASHIMOTO, K. & MATSUMOTO, N. (1991). Functions of a co-transmitter, calcitonin gene-related peptide, on the neuromuscular junction. Advances in Experimental Medicine and Biology 287, 39-50.
30. VAN DER KLOOT, W. (1987). Pretreatment with hypertonic solutions increases quantal size at the frog neuromuscular junction. Journal of Neurophysiology 57, 1536-1554.
31. VAN DER KLOOT, W. (1988). The packing of acetylcholine into quanta at the frog neuromuscular junction is inhibited by increases in intracellular sodium. Pflügers Archiv 412, 258-263.
32. VAN DER KLOOT, W. (1991). Down-regulation of quantal size at frog neuromuscular junctions: possible roles for elevated intracellular calcium and for protein kinase C. Journal of Neurobiology 22, 204-214.
33. VAN DER KLOOT, W. (1994). Anandamide, a naturally-occurring agonist of the cannabinoid receptor, blocks adenylate cyclase at the frog neuromuscular junction. Brain Research 649, 181-184.
34. VAN DER KLOOT, W., BALEZINA, O. P., MOLGÓ, J. & NAVES, L. A. (1994). The timing of channel opening during miniature endplate currents at the frog and mouse neuromuscular junctions: effects of fasciculin-2, other anti-cholinesterases and vesamicol. Pflügers Archiv 428, 114-126.
35. VAN DER KLOOT, W. & BRANISTEANU, D. D. (1992). Effects of activators and inhibitors of protein kinase A on increases in quantal size at the frog neuromuscular junction. Pflügers Archiv 420, 336-341.
36. VAN DER KLOOT, W. & MOLGÓ, J. (1994). Quantal acetylcholine release at the vertebrate neuromuscular junction. Physiological Reviews 74, 899-991.
37. XU, X.-J. & WIESENFELD-HALLIN, Z. (1996). Calcitonin gene-related peptide (8-37) does not antagonize calcitonin gene-related peptide in rat spinal cord. Neuroscience Letters 204, 185-188.